rs55907031
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000552.5(VWF):c.998-27C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.12 in 1,570,608 control chromosomes in the GnomAD database, including 13,291 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.16 ( 2536 hom., cov: 32)
Exomes 𝑓: 0.12 ( 10755 hom. )
Consequence
VWF
NM_000552.5 intron
NM_000552.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0250
Genes affected
VWF (HGNC:12726): (von Willebrand factor) This gene encodes a glycoprotein involved in hemostasis. The encoded preproprotein is proteolytically processed following assembly into large multimeric complexes. These complexes function in the adhesion of platelets to sites of vascular injury and the transport of various proteins in the blood. Mutations in this gene result in von Willebrand disease, an inherited bleeding disorder. An unprocessed pseudogene has been found on chromosome 22. [provided by RefSeq, Oct 2015]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 12-6072469-G-A is Benign according to our data. Variant chr12-6072469-G-A is described in ClinVar as [Benign]. Clinvar id is 256705.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.293 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.158 AC: 24039AN: 152012Hom.: 2529 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
24039
AN:
152012
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.122 AC: 29991AN: 246360 AF XY: 0.123 show subpopulations
GnomAD2 exomes
AF:
AC:
29991
AN:
246360
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.115 AC: 163641AN: 1418476Hom.: 10755 Cov.: 25 AF XY: 0.116 AC XY: 82469AN XY: 708062 show subpopulations
GnomAD4 exome
AF:
AC:
163641
AN:
1418476
Hom.:
Cov.:
25
AF XY:
AC XY:
82469
AN XY:
708062
Gnomad4 AFR exome
AF:
AC:
9637
AN:
32654
Gnomad4 AMR exome
AF:
AC:
2683
AN:
44552
Gnomad4 ASJ exome
AF:
AC:
1473
AN:
25780
Gnomad4 EAS exome
AF:
AC:
6671
AN:
39472
Gnomad4 SAS exome
AF:
AC:
14217
AN:
85198
Gnomad4 FIN exome
AF:
AC:
5714
AN:
53016
Gnomad4 NFE exome
AF:
AC:
115140
AN:
1073132
Gnomad4 Remaining exome
AF:
AC:
7432
AN:
58986
Heterozygous variant carriers
0
7255
14509
21764
29018
36273
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
4324
8648
12972
17296
21620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.158 AC: 24072AN: 152132Hom.: 2536 Cov.: 32 AF XY: 0.157 AC XY: 11662AN XY: 74354 show subpopulations
GnomAD4 genome
AF:
AC:
24072
AN:
152132
Hom.:
Cov.:
32
AF XY:
AC XY:
11662
AN XY:
74354
Gnomad4 AFR
AF:
AC:
0.297067
AN:
0.297067
Gnomad4 AMR
AF:
AC:
0.0836057
AN:
0.0836057
Gnomad4 ASJ
AF:
AC:
0.0495392
AN:
0.0495392
Gnomad4 EAS
AF:
AC:
0.176209
AN:
0.176209
Gnomad4 SAS
AF:
AC:
0.168393
AN:
0.168393
Gnomad4 FIN
AF:
AC:
0.108782
AN:
0.108782
Gnomad4 NFE
AF:
AC:
0.104068
AN:
0.104068
Gnomad4 OTH
AF:
AC:
0.128314
AN:
0.128314
Heterozygous variant carriers
0
969
1939
2908
3878
4847
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
260
520
780
1040
1300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
615
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Mar 28, 2020
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
von Willebrand disease type 2 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
von Willebrand disease type 3 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
von Willebrand disease type 1 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at